Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jan 2017 for Rocket Pharmaceuticals, INC..
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +13.3%Entry US$24.08 · Close at T+365 US$27.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Devon Park Bioventures LP: trading record in brief
This profile gathers the share dealings of Devon Park Bioventures LP across 2 companies, led by ZS Pharma, Inc. and Rocket Pharmaceuticals, Inc. We count 11 filings; the first trade dates from 23 June 2014 and the latest from 4 January 2017.
Every open-market trade on record is a purchase: 2 purchases worth €6.4M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 6 January 2017: a transaction, in Rocket Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,259 days ago, on 25 February 2015. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Devon Park Bioventures LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
9,857 shares0Common StockSEC:0001140361-17-001008:1
3,243,709 shares0Common StockSEC:0001140361-17-001008:0
9,748 shares@ US$90.00Common StockSEC:0000899243-15-010249:0
2,576,724 shares@ US$90.00Common StockSEC:0000899243-15-010249:1
2,323,610 sharesCommon StockSEC:0001209191-15-018745:0
105,933 sharesCommon StockSEC:0001209191-15-018745:1
814,166 shares@ US$6.00Common StockSEC:0001209191-15-018745:2
Canonical exit: 24 May 2015 (T+90)
1,422,901 sharesCommon StockSEC:0001209191-14-043672:0
824,913 sharesCommon StockSEC:0001209191-14-043672:1
168,910 sharesCommon StockSEC:0001209191-14-043672:2
160,000 shares@ US$18.00Common StockSEC:0001209191-14-043672:3
Canonical exit: 21 Sept 2014 (T+90)
11 of 11 declarations
